webinar register page

RedChip Investor Group Call with BioVie Inc. (NASDAQ: BIVI)
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI.

00:37:00

* Required information
Loading